lamotrigine has been researched along with Cognitive Decline in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We conducted a double-blind crossover study of a low dose (15 mg, 'placebo') and an active dose (195 mg) of methylene blue in patients with bipolar disorder treated with lamotrigine." | 9.24 | Methylene blue treatment for residual symptoms of bipolar disorder: randomised crossover study. ( Alda, M; Blagdon, R; Dursun, S; Garnham, J; Hajek, T; MacLellan, S; MacQueen, G; McKinnon, M; Nair, C; O'Donovan, C, 2017) |
| "Lamotrigine (LTG) is a broad-spectrum antiepileptic drug that is widely used in clinic." | 5.46 | Effect of lamotrigine on epilepsy-induced cognitive impairment and hippocampal neuronal apoptosis in pentylenetetrazole-kindled animal model. ( Dong, RF; Tian, S; Wang, WP; Zhang, B; Zhang, C; Zhang, JW, 2017) |
| "We conducted a double-blind crossover study of a low dose (15 mg, 'placebo') and an active dose (195 mg) of methylene blue in patients with bipolar disorder treated with lamotrigine." | 5.24 | Methylene blue treatment for residual symptoms of bipolar disorder: randomised crossover study. ( Alda, M; Blagdon, R; Dursun, S; Garnham, J; Hajek, T; MacLellan, S; MacQueen, G; McKinnon, M; Nair, C; O'Donovan, C, 2017) |
| "Lamotrigine (LTG) is a broad-spectrum antiepileptic drug that is widely used in clinic." | 1.46 | Effect of lamotrigine on epilepsy-induced cognitive impairment and hippocampal neuronal apoptosis in pentylenetetrazole-kindled animal model. ( Dong, RF; Tian, S; Wang, WP; Zhang, B; Zhang, C; Zhang, JW, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhuo, C | 1 |
| Zhou, C | 1 |
| Tian, H | 1 |
| Li, Q | 1 |
| Chen, J | 1 |
| Yang, L | 1 |
| Zhang, Q | 1 |
| Li, R | 1 |
| Ma, X | 1 |
| Cai, Z | 1 |
| Chen, G | 1 |
| Xu, Y | 1 |
| Song, X | 1 |
| Huber-Mollema, Y | 1 |
| van Iterson, L | 1 |
| Oort, FJ | 1 |
| Lindhout, D | 1 |
| Rodenburg, R | 1 |
| Alda, M | 1 |
| McKinnon, M | 1 |
| Blagdon, R | 1 |
| Garnham, J | 1 |
| MacLellan, S | 1 |
| O'Donovan, C | 1 |
| Hajek, T | 1 |
| Nair, C | 1 |
| Dursun, S | 1 |
| MacQueen, G | 1 |
| Zhang, B | 1 |
| Zhang, JW | 1 |
| Wang, WP | 1 |
| Dong, RF | 1 |
| Tian, S | 1 |
| Zhang, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Double-Blind Trial of Methylene Blue for Cognitive Dysfunction in Bipolar Disorder[NCT00214877] | Phase 3 | 40 participants (Anticipated) | Interventional | 2003-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for lamotrigine and Cognitive Decline
| Article | Year |
|---|---|
Methylene blue treatment for residual symptoms of bipolar disorder: randomised crossover study.
Topics: Adult; Anxiety; Bipolar Disorder; Cognitive Dysfunction; Cross-Over Studies; Depression; Double-Blin | 2017 |
3 other studies available for lamotrigine and Cognitive Decline
| Article | Year |
|---|---|
Lithium produces bi-directionally regulation of mood disturbance, acts synergistically with anti-depressive/-manic agents, and did not deteriorate the cognitive impairment in murine model of bipolar disorder.
Topics: Animals; Anticonvulsants; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Cognitive Dysfu | 2022 |
Neurocognition after prenatal levetiracetam, lamotrigine, carbamazepine or valproate exposure.
Topics: Anticonvulsants; Carbamazepine; Child; Child Development; Cognitive Dysfunction; Female; Humans; Lam | 2020 |
Effect of lamotrigine on epilepsy-induced cognitive impairment and hippocampal neuronal apoptosis in pentylenetetrazole-kindled animal model.
Topics: Animals; Anticonvulsants; Apoptosis; CA1 Region, Hippocampal; Cognitive Dysfunction; Epilepsy; Femal | 2017 |